Plasmid-borne extended-spectrum β-lactamase in a clinical isolate of Acinetobacter baumannii [1]

Journal of Medical Microbiology

Volumn 52, Issue 12, 2003, Pages 1125-1127

  Joshi, Suresh G ^a,b   Litake, Geetanjali M ^a   Ghole, Vikram S ^a   Niphadkar, Krishnarao B ^a  

^a KEM HOSPITAL   (India)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; CEFAZOLIN; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; PLASMID DNA; RIFAMPICIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; CONTROLLED STUDY; ESCHERICHIA COLI; INTENSIVE CARE UNIT; LETTER; NONHUMAN; PLASMID; PRIORITY JOURNAL; TEACHING HOSPITAL; WOUND INFECTION; ANTIBIOTIC RESISTANCE; BACTERIUM CONJUGATION; BIOSYNTHESIS; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN;

ACINETOBACTER BAUMANNII; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CONJUGATION, GENETIC; HUMANS; PLASMIDS;

EID: 1542750252     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-52-12-1125     Document Type: Letter

References (17)

1. Bergogne-Berezin, E. (2001). The increasing role of Acinetobacter species as nosocomial pathogens. Curr Infect Dis Rep 3, 440-444.
2. Bergogne-Berezin, E. & Towner, K. J. (1996). Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9, 148-165.
3. Bouvet, P. J. M. & Grimont, P. A. D. (1987). Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol 138, 569-578.
4. Dy, M. E., Nord, J. A., LaBombardi, V. J. & Kislak, J. W. (1999). The emergence of resistant strains of Acinetobacter baumannii: clinical and infection control implications. Infect Control Hasp Epidemiol 20, 565-567.
5. Jarlier, V., Nicolas, M. H., Fournier, G. & Philippon, A. (1988). Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10, 867-878.
6. Joshi, S. G. (1998). Assignment of antibiotic resistance to naturally occurring plasmids from clinical isolates of Acinetobacter species. PhD thesis, University of Pune, Pune, India.
7. Joshi, S. G., Litake, G. M., Niphadkar, K. B. & Ghole, V. S. (2003). Multidrug resistant Acinetobacter baumannii isolates from a teaching hospital. J Infect Chemother 9, 187-190.
8. Levin, A. S., Levy, C. E., Manrique, A. E. I., Medeiros, E. A. S. & Costa, S. F. (2003). Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int J Antimicrob Agents 21, 58-62.
9. Mulvey, M. R., Soule, G., Boyd, D., Demczuk, W. & Ahmed, R. (2003). Characterization of the first extended-spectrum β-lactamase-producing Salmonella isolate identified in Canada. Multi-provincial Salmonella typhimurium Case Control Study Group. J Clin Microbiol 41, 460-462.
10. NCCLS (1997). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A4. Villanova, PA: National Committee for Clinical Laboratory Standards.
11. Perilli, M., Felici, A., Oratore, A., Cornaglia, G., Bonfiglio, G., Rossolini, G. M. & Amicosante, G. (1996). Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother 40, 715-719.
12. Poirel, L., Karim, A., Mercat, A., Le Thomas, I., Vahaboglu, H., Richard, C. & Nordmann, P. (1999). Extended-spectrum β-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. J Antimicrob Chemother 43, 157-158.
13. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
14. Stanisich, V. A. (1988). Identification and analysis of plasmids at the genetic level. Methods Microbiol 21, 11-48.
15. Vahaboglu, H., Coskunkan, F., Tansel, O. & 10 other authors (2001). Clinical importance of extended-spectrum β-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains. J Med Microbiol 50, 642-645.
16. Von Graevenitz, A. (1995). Acinetobacter, Alcaligenes, Moraxella and other non-fermentative gram-negative bacteria. In Manual of Clinical Microbiology, pp. 520-532. Edited by P. J. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover & R. H. Yolken. Washington, DC: American Society of Microbiology.
17. Willets, N. (1988). Conjugation. Methods Microbiol 21, 49-75.